Safety of Outpatient Closed-Loop Control: First Randomized Crossover Trials of a Wearable Artificial Pancreas

OBJECTIVE: We estimate the effect size of hypoglycemia risk reduction on closed-loop control (CLC) versus open-loop (OL) sensor-augmented insulin pump therapy in supervised outpatient setting. RESEARCH DESIGN AND METHODS: Twenty patients with type 1 diabetes initiated the study at the Universities o...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
Main Authors: Kovatchev, Boris P., Renard, Eric, Cobelli, Claudio, Zisser, Howard C., Keith-Hynes, Patrick, Anderson, Stacey M., Brown, Sue A., Chernavvsky, Daniel R., Breton, Marc D., Mize, Lloyd B., Farret, Anne, Place, Jérôme, Bruttomesso, Daniela, Del Favero, Simone, Boscari, Federico, Galasso, Silvia, Avogaro, Angelo, Magni, Lalo, Di Palma, Federico, Toffanin, Chiara, Messori, Mirko, Dassau, Eyal, Doyle, Francis J.
פורמט: Artigo
שפה:Inglês
יצא לאור: American Diabetes Association 2014
נושאים:
Diabetes Care Symposium
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC4067397/
https://ncbi.nlm.nih.gov/pubmed/24929429
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/dc13-2076
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים